Aurion Biotech announced the appointment of Marjan Farid, MD, as Chair of its Medical Advisory Board (MAB).

Dr. Farid, a cornea, cataract and refractive surgeon at the Gavin Herbert Eye Institute at the University of California, Irvine (UCI), is a global educator and researcher in ophthalmology and currently serves as Chair of the Cornea Clinical Committee of the American Society of Cataract and Refractive Surgery (ASCRS).

“Aurion welcomes a deeply respected clinical leader whose unique experience and leadership will bring critical insights to guide the company through the next stage of development and beyond,” said Edward J. Holland, MD, Chief Medical Officer of Aurion Biotech. “Dr. Farid has spent her career advancing patient care, driving innovation and informing strategic decision-making. Her expertise will complement Aurion’s MAB as we grow our pipeline of transformative regenerative medicines.”

At UCI, Dr. Farid serves as Director of Cornea, Cataract and Refractive Surgery and is a Clinical Professor at the Gavin Herbert Eye Institute. She also founded the UCI Severe Ocular Surface Disease Program, the first Center of Excellence supported by the Holland Foundation for Sight Restoration. The program focuses on providing advanced care to patients with severe ocular surface diseases while advancing research and education in this specialized field.

“I’ve dedicated my career to advancing patient care and addressing some of the most complex unmet needs in ophthalmology,” Dr. Farid said. “Aurion is on the cusp of transforming corneal care in the United States and restoring vision for millions of patients worldwide. I’m honored to be part of this incredible endeavor to bring a potential cure for blindness caused by corneal endothelial disease.”

Aurion Biotech is advancing regenerative cell therapies designed to restore vision in patients with corneal endothelial disease. The company’s research and development efforts aim to expand access to innovative treatments that could significantly improve outcomes for patients affected by this condition.